Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Pfizer Inc. (NYSEFE) has notified Pain Therapeutics, Inc. (NASDAQ: PTIE) that it has decided to discontinue its agreement to develop and commercialize REMOXY™ (oxycodone) Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone. Pfizer will return all rights, including responsibility for regulatory activities, to Pain Therapeutics, Inc.

Holy s**t - 20K shares of IPCI now makes you a millionaire in 4 to 5 years... maybe sooner.

Fair buyout offer from Pfizer - $500 Million up front = 16.00 share + voucher good for $500 Million when/if Rexista gets FDA approval, + voucher good for $500 Million when/if Regabatin gets FDA approval - 1.5B total buyout to Pfizer - $48.00 share possible to present shareholders within 4 years.

assumes 30M fully diluted shares